ANDA 65024, held by Sciegen Pharms. Gentamicin Sulfate.
As of Nov 15, 2026, ANDA 65024 (Gentamicin Sulfate), held by Sciegen Pharms, was first approved by FDA on Jul 30, 2004, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 30, 2004 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Gentamicin SulfateEQ 0.3% BASE ยท ointment;ophthalmic | Gentamicin Sulfate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
